Using Healthcare Failure Mode and Effect Analysis in prospective medication safety risk management in secondary care inpatient wards.
| Autor: | Sova PM; Lapland Hospital District, Rovaniemi, Lapland, Finland paivi.sova@lshp.fi., Holmström AR; Faculty of Pharmacy, University of Helsinki, Helsinki, Finland., Airaksinen M; Faculty of Pharmacy, University of Helsinki, Helsinki, Finland., Sneck S; Oulu University Hospital, Oulu, Finland. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2024 Apr 23; Vol. 31 (3), pp. 227-233. Date of Electronic Publication: 2024 Apr 23. |
| DOI: | 10.1136/ejhpharm-2021-003109 |
| Abstrakt: | Objectives: The evaluation and improvement of medication management processes is an essential part of preventive medication risk management strategies in hospitals. The aim of the present study was to identify and analyse risks of a new electronic medication management process and to suggest improvements to manage the identified risks in a secondary care hospital. Methods: The electronic medication management process of four wards at the Lapland Central Hospital, Finland was evaluated by Healthcare Failure Mode and Effect Analysis (HFMEA). The multidisciplinary HFMEA team consisted of five experts who identified the failure modes and rated their hazard scores (scale of 1-16). In addition, the patient safety incident reports of the hospital were used for identification of failure modes. Safety recommendations were identified, prioritised and implemented with a follow-up evaluation. Results: The team identified five phases in the electronic medication management process. Altogether, 35 potential failure modes were found, with eight being classified as the most severe (hazard score >8). The given recommendations (n=15) concerned improvements to the electronic medical record (EMR) (n=8) and to the work processes of the wards (n=7). Only two of the recommendations were fully implemented, and five were under development or partly implemented after a 15-month follow-up period. Conclusions: For identifying risks associated with electronic medication management and for compiling related safety recommendations, triangulation of different risk identification methodologies is recommended. When implementing electronic medication management, appropriate patient identification in medication administration should be ensured together with EMR development. Systematic efforts should be made for the effective implementation of the safety recommendations. Further research is warranted to explore barriers to implementing safety improvements, especially in small healthcare units in rural areas. Competing Interests: Competing interests: None declared. (© European Association of Hospital Pharmacists 2024. No commercial re-use. See rights and permissions. Published by BMJ.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|